Search results
Showing 286 to 300 of 303 results for breast cancer
Awaiting development [GID-TA11273] Expected publication date: TBC
Awaiting development [GID-TA11342] Expected publication date: TBC
Awaiting development [GID-TA11487] Expected publication date: TBC
In development [GID-TA11090] Expected publication date: TBC
In development [GID-NG10419] Expected publication date: 31 March 2025
Sacituzumab govitecan for untreated PD-L1-negative triple-negative advanced breast cancer ID6433
Awaiting development [GID-TA11489] Expected publication date: TBC
In development [GID-TA11263] Expected publication date: TBC
In development [GID-TA11513] Expected publication date: TBC
We are listening to your views on this NICE guideline. Comments close 19 April 2024.
Awaiting development [GID-TA11519] Expected publication date: TBC
In development [GID-TA11318] Expected publication date: TBC
In development [GID-TA11439] Expected publication date: TBC
In development [GID-TA11514] Expected publication date: 25 September 2024
Awaiting development [GID-TA11535] Expected publication date: TBC
chemotherapy after surgery for early breast cancer More people with early breast cancer could be spared chemotherapy and